Trademarkia Logo

Australia

AU$
Trademark Search
GENE REWRITER

View On IPO.GOV.AU

GENE REWRITER
Not protected: Not accepted

Last updated on 26 Jun 2024

Owner Info

TESSERA THERAPEUTICS, INC.

101 South Street, Suite 300

Somerville MA 02143, UNITED STATES OF AMERICA

Serial Number

2191245 filed on 22 Jan 2021

Correspondent

Christina M. Licursi, Esq. Wolf, Greenfield & Sacks, P.C.

600 Atlantic Avenue,

Boston MA 02210,

UNITED STATES OF AMERICA

GENE REWRITER

Classification Information

Class [001]
Chemical and biological agents for scientific and research use, namely, for manipulating or modifying DNA.

Class [005]
Reagents for medical use, namely, molecular and cellular biology reagents and assays for the modification of cells and DNA; pharmaceutical preparation Read More

Class [042]
Research and development in the field of technology and engineering for the modification of DNA; development of new technology for others for enabling Read More

Mark Details

Serial Number

2191245

Registered On

NA

Renewal On

NA

Mark Type

WORD

Priority Claim (Convention Details)

Date

24 Jul 2020

Mark Type

US

Legal History

Show more

Status DateAction Taken
26th Jun 2024International Registration in Australia Refused correspondence sent
25th Jun 2024Status change to Lapsed/Not Protected
21st May 2024Extension of Time Granted correspondence sent
21st May 2024Extension of Time Granted
15th May 2024Extension of Time Requested
12th Apr 2024Extension of Time Granted correspondence sent
12th Apr 2024Extension of Time Granted
12th Apr 2024Extension of Time Requested
21st Feb 2024Extension of Time Granted correspondence sent
21st Feb 2024Extension of Time Granted